POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Ontario recommends Pfizer-BioNTech COVID-19 vaccine to 18-24 years old

Christian Fernsby |
Ontario is issuing a preferential recommendation of the use of Pfizer-BioNTech vaccine for individuals aged 18-24 years old effective immediately based on the current available analysis from Ontario’s adverse events following immunization (AEFI) surveillance system.

Article continues below




This recommendation was based on the advice of Ontario’s Children COVID-19 Vaccine Table, Ontario Vaccine Clinical Advisory Group, and Public Health Ontario and is due to an observed increase in Ontario of the very rare heart condition called pericarditis/myocarditis following vaccination with Moderna compared to Pfizer in the 18 to 24 year old age group, particularly among males.

The majority of reported cases have been mild with individuals recovering quickly, normally with anti-inflammatory medication. Symptoms have typically been reported to start within one week after vaccination, more commonly after the second dose.

This decision is also based on the increased and reliable supply of the Pfizer vaccines and the fact that individuals who received Moderna for their first dose can safely take the Pfizer-BioNTech vaccine for their second dose.

Mixing vaccines is safe and effective, and full vaccination with two doses of the mRNA vaccine offers the greatest protection you can have against COVID-19 and the Delta variant.

Should individuals aged 18 to 24-year old wish to receive Moderna they can continue to do so with informed consent. The province will continue using the Pfizer vaccine for youth ages 12-17 (including those turning 12 in 2021).


What to read next

Pfizer says kids 12 to 15 respond great to vaccine
Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people
WHO validates Sinovac COVID-19 vaccine for emergency use